Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Abdelbaset A Elzagallaai

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|July 14, 2010
Pharmacogenetic screeningAbdelbaset A Elzagallaai
British Journal of Clinical Pharmacology|December 15, 2022
Pathophysiology of drug hypersensitivityAbdelbaset A Elzagallaai, Michael J Rieder
Methods in Molecular Biology (Clifton, N.J.)|September 6, 2022
Pharmacogenomics in ChildrenMichael J Rieder, Abdelbaset A Elzagallaai
Expert Review of Clinical Pharmacology|July 11, 2022
Genetic markers of drug hypersensitivity in pediatrics: current state and promiseAbdelbaset A Elzagallaai, Michael J Rieder
Expert Review of Clinical Pharmacology|November 29, 2023
Novel insights into molecular and cellular aspects of delayed drug hypersensitivity reactionsAbdelbaset A Elzagallaai, Michael J Rieder
Frontiers in Pharmacology|May 17, 2021
Model Based Evaluation of Hypersensitivity Adverse Drug Reactions to Antimicrobial Agents in ChildrenAbdelbaset A Elzagallaai, Michael J Rieder
British Journal of Clinical Pharmacology|September 10, 2014
In vitro testing for diagnosis of idiosyncratic adverse drug reactions: Implications for pathophysiologyAbdelbaset A Elzagallaai, Michael J Rieder
Journal of Clinical Pharmacology|May 15, 2013
The predictive value of the in vitro platelet toxicity assay (iPTA) for the diagnosis of hypersensitivity reactions to sulfonamidesAbdelbaset A Elzagallaai, Gideon Koren, Michael J Rieder
Journal of Clinical Pharmacology|April 20, 2010
The in vitro platelet toxicity assay (iPTA): a novel approach for assessment of drug hypersensitivity syndromeAbdelbaset A Elzagallaai, Michael J Rieder, Gideon Koren
Expert Opinion on Drug Metabolism & Toxicology|January 22, 2025
A comprehensive update on the <i>human leukocyte antigen</i> and idiosyncratic adverse drug reactionsAbdelbaset A Elzagallaai, Awatif M Abuzgaia, Michael J Rieder
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|July 14, 2010
Pharmacogenetic screeningAbdelbaset A Elzagallaai
British Journal of Clinical Pharmacology|December 15, 2022
Pathophysiology of drug hypersensitivityAbdelbaset A Elzagallaai, Michael J Rieder
Methods in Molecular Biology (Clifton, N.J.)|September 6, 2022
Pharmacogenomics in ChildrenMichael J Rieder, Abdelbaset A Elzagallaai
Expert Review of Clinical Pharmacology|July 11, 2022
Genetic markers of drug hypersensitivity in pediatrics: current state and promiseAbdelbaset A Elzagallaai, Michael J Rieder
Expert Review of Clinical Pharmacology|November 29, 2023
Novel insights into molecular and cellular aspects of delayed drug hypersensitivity reactionsAbdelbaset A Elzagallaai, Michael J Rieder
Frontiers in Pharmacology|May 17, 2021
Model Based Evaluation of Hypersensitivity Adverse Drug Reactions to Antimicrobial Agents in ChildrenAbdelbaset A Elzagallaai, Michael J Rieder
British Journal of Clinical Pharmacology|September 10, 2014
In vitro testing for diagnosis of idiosyncratic adverse drug reactions: Implications for pathophysiologyAbdelbaset A Elzagallaai, Michael J Rieder
Journal of Clinical Pharmacology|May 15, 2013
The predictive value of the in vitro platelet toxicity assay (iPTA) for the diagnosis of hypersensitivity reactions to sulfonamidesAbdelbaset A Elzagallaai, Gideon Koren, Michael J Rieder
Journal of Clinical Pharmacology|April 20, 2010
The in vitro platelet toxicity assay (iPTA): a novel approach for assessment of drug hypersensitivity syndromeAbdelbaset A Elzagallaai, Michael J Rieder, Gideon Koren
Expert Opinion on Drug Metabolism & Toxicology|January 22, 2025
A comprehensive update on the <i>human leukocyte antigen</i> and idiosyncratic adverse drug reactionsAbdelbaset A Elzagallaai, Awatif M Abuzgaia, Michael J Rieder
Pageof 3